InsiderClue
Stocks · Health care · Services-Commercial Physical & Biological Research

Incyte

INCY Clue Score71
United States Fiscal year ends December CIK 0000879169 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

23
Insider
Date
Role
Action
Shares
Price
Amount
Pablo J Cagnoni
15 Oct 2026
President, Global Head of R&D
Sold after exercise
2,642
$112.71
$297.78K
Pablo J Cagnoni
15 Sep 2026
President, Global Head of R&D
Sold after exercise
13,985
$120.49
$1.69M
Pablo J Cagnoni
15 Sep 2026
President, Global Head of R&D
Sold after exercise
9,233
$120.50
$1.11M
Patrick A Mayes
5 Aug 2026
EVP & Chief Scientific Officer
Sold after exercise
2,207
$123.99
$273.65K
Patrick A Mayes
3 Aug 2026
EVP & Chief Scientific Officer
Sold after exercise
6,055
$120.43
$729.20K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
2,293
$119.41
$273.81K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
326
$121.69
$39.67K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
85
$122.19
$10.39K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
1,642
$119.38
$196.02K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
1,643
$119.51
$196.35K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
2,864
$119.40
$341.96K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
4,695
$119.39
$560.54K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
6,171
$119.43
$737.00K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
2,187
$119.47
$261.28K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
5,332
$119.42
$636.75K
Patrick A Mayes
31 Jul 2026
EVP & Chief Scientific Officer
Sold after exercise
14,661
$119.46
$1.75M
Thomas Tray
4 Jun 2026
Principal Accounting Officer
Sold after exercise
2,639
$100.00
$263.90K
Paul J Clancy
19 May 2026
Director
Sold after exercise
15,000
$94.93
$1.42M
Pablo J Cagnoni
17 Apr 2026
President, Global Head of R&D
Sold after exercise
18,667
$96.50
$1.80M
Pablo J Cagnoni
17 Mar 2026
President, R&D
Sold after exercise
18,667
$94.24
$1.76M
Pablo J Cagnoni
19 Feb 2026
President, R&D
Sold after exercise
18,668
$100.91
$1.88M
Thomas Tray
19 Dec 2025
Principal Accounting Officer
Sold after exercise
2,774
$100.00
$277.40K
Sheila A. Denton
17 Nov 2025
EVP & General Counsel
Sold after exercise
278
$104.36
$29.01K
Show all 48 transactions →

What was left out

Form 4 filings counted 91
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 22
Sales straight out of an exercise 23
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 688,231
History held since 13 Oct 2006